Courage, collaboration, complexity and chemotherapy safety: the view from the sharp end.

Area of Science:

• Oncology Nursing
• Patient Safety
• Chemotherapy Administration

Background:

• A fatal fluorouracil overdose in 2006 revealed critical gaps in Canadian intravenous ambulatory chemotherapy safety protocols.
• Existing safety checks and balances were insufficient to prevent medication errors.
• The incident prompted immediate changes in practice nationwide but highlighted the need for further investigation.

Purpose of the Study:

• To conduct an 18-month exploratory study on safety issues in intravenous ambulatory chemotherapy in Canada.
• To identify key safety concerns and develop actionable recommendations for oncology nurses and the broader healthcare system.
• To share insights gained from the study to improve patient safety and care delivery.

Main Methods:

• An interdisciplinary, pan-Canadian team was assembled to investigate chemotherapy safety.
• An 18-month exploratory study was conducted.
• The study culminated in a report detailing safety issues and recommendations.

Main Results:

• Several significant safety issues were identified within intravenous ambulatory chemotherapy administration in Canada.
• The study provided specific recommendations for improving safety.
• Key insights emphasize the need for courage in disclosing safety concerns, collaborative improvement efforts, and system simplification.

Conclusions:

• Oncology nurses require courage to report safety concerns to drive improvements.
• Collaboration among healthcare professionals is essential for developing effective safety enhancements.
• Simplifying processes upstream and throughout the system is crucial for enhancing safety at the point of care.